{"id":"https://openalex.org/W2890625366","doi":"https://doi.org/10.3389/fonc.2018.00337","title":"Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin","display_name":"Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin","alternate_titles":[],"publication_year":2018,"publication_date":"2018-09-05","ids":{"openalex":"https://openalex.org/W2890625366","doi":"https://doi.org/10.3389/fonc.2018.00337","mag":"2890625366","pmid":"https://pubmed.ncbi.nlm.nih.gov/30234012","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6134055"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2018.00337","doi":"https://doi.org/10.3389/fonc.2018.00337","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2018.00337","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2018.00337/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2890625366"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2018.00337/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006536741","display_name":"Marshall Hunter Joyce","orcid":"https://orcid.org/0000-0001-9351-653X","observed_orcids":["https://orcid.org/0000-0001-9351-653X"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Hunter Joyce","raw_affiliation_strings":["Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056794126","display_name":"Carolyne Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyne Lu","raw_affiliation_strings":["Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Emily R. James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily R. James","raw_affiliation_strings":["Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072667598","display_name":"Rachel A. Hegab","orcid":"https://orcid.org/0000-0003-1333-8169","observed_orcids":["https://orcid.org/0000-0003-1333-8169"]},"institutions":[{"id":"https://openalex.org/I919208787","display_name":"Louisiana Tech University","ror":"https://ror.org/04q9esz89","country_code":"US","type":"education","lineage":["https://openalex.org/I2799628689","https://openalex.org/I919208787"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Hegab","raw_affiliation_strings":["Department of Biomedical Engineering, Louisiana Tech University, Ruston, LA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Louisiana Tech University, Ruston, LA, United States","institution_ids":["https://openalex.org/I919208787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022007467","display_name":"Shane C. Allen","orcid":"https://orcid.org/0000-0002-4107-946X","observed_orcids":["https://orcid.org/0000-0002-4107-946X"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shane C. Allen","raw_affiliation_strings":["Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073997385","display_name":"Laura J. Suggs","orcid":"https://orcid.org/0000-0002-1419-8017","observed_orcids":["https://orcid.org/0000-0002-1419-8017"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura J. Suggs","raw_affiliation_strings":["Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049347342","display_name":"Amy Brock","orcid":"https://orcid.org/0000-0001-8255-9024","observed_orcids":["https://orcid.org/0000-0001-8255-9024"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Amy Brock","raw_affiliation_strings":["Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, United States","institution_ids":["https://openalex.org/I86519309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5049347342"],"corresponding_institution_ids":["https://openalex.org/I86519309"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":5.4064,"has_fulltext":true,"cited_by_count":151,"citation_normalized_percentile":{"value":0.97421168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"8","issue":null,"first_page":"337","last_page":"337"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10379","display_name":"Cellular Mechanics and Interactions","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10379","display_name":"Cellular Mechanics and Interactions","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extracellular-matrix-stiffness","display_name":"extracellular matrix stiffness","score":0.6209999918937683},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9010000228881836},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.8960000276565552},{"id":"https://openalex.org/keywords/yap-nuclear-translocation","display_name":"YAP nuclear translocation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.6010000109672546},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.9039999842643738},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9700000286102295},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6579999923706055},{"id":"https://openalex.org/keywords/mechanotransduction","display_name":"mechanotransduction","score":0.7269999980926514},{"id":"https://openalex.org/keywords/mesenchymal-differentiation","display_name":"mesenchymal differentiation","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.7429309487342834},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6452220678329468},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5530845522880554},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5211567878723145},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5195879936218262},{"id":"https://openalex.org/C2779372316","wikidata":"https://www.wikidata.org/wiki/Q569057","display_name":"Stiffness","level":2,"score":0.4469543695449829},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.43473148345947266},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4163599908351898},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3895222842693329},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3820507228374481},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.363472580909729},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.317761093378067},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26322251558303833},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.24783149361610413},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20914533734321594},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fonc.2018.00337","doi":"https://doi.org/10.3389/fonc.2018.00337","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2018.00337","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2018.00337/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5094074","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6134055","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30234012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30234012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6134055","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6134055/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:644aa27f532b4c8e83795fd7c0291d7a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/644aa27f532b4c8e83795fd7c0291d7a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 8 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2018.00337","doi":"https://doi.org/10.3389/fonc.2018.00337","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2018.00337","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2018.00337/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2745015503","display_name":"High resolution cell lineage tracking and isolation","funder_award_id":"R21CA212928","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4120661768","display_name":"The Allee Effect in Tumor Initiation","funder_award_id":"R01CA226258","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4798722601","display_name":"REU Site: BME Community of Undergraduate Research Scholars for Cancer (BME CUReS Cancer)","funder_award_id":"1757885","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"},{"id":"https://openalex.org/G6933051273","display_name":"The Influence of Tumor Stiffness on Therapeutic Efficacy","funder_award_id":"RP130372","funder_id":"https://openalex.org/F4320308129","funder_display_name":"Cancer Prevention and Research Institute of Texas"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320306260","display_name":"Breast Cancer Research Foundation","ror":"https://ror.org/0348ff195"},{"id":"https://openalex.org/F4320308129","display_name":"Cancer Prevention and Research Institute of Texas","ror":"https://ror.org/0003xa228"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2890625366.pdf","grobid_xml":"https://content.openalex.org/works/W2890625366.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W9019541","https://openalex.org/W1541555963","https://openalex.org/W1871742131","https://openalex.org/W1970199527","https://openalex.org/W1995592152","https://openalex.org/W1999459611","https://openalex.org/W2009370455","https://openalex.org/W2011551229","https://openalex.org/W2016126437","https://openalex.org/W2021808705","https://openalex.org/W2030233835","https://openalex.org/W2033998652","https://openalex.org/W2034269086","https://openalex.org/W2040430549","https://openalex.org/W2042240216","https://openalex.org/W2045295282","https://openalex.org/W2055880222","https://openalex.org/W2061058076","https://openalex.org/W2061138960","https://openalex.org/W2099052265","https://openalex.org/W2100122781","https://openalex.org/W2100303404","https://openalex.org/W2101151845","https://openalex.org/W2103049535","https://openalex.org/W2112451226","https://openalex.org/W2115124692","https://openalex.org/W2117692326","https://openalex.org/W2118739155","https://openalex.org/W2123511906","https://openalex.org/W2132264180","https://openalex.org/W2136737404","https://openalex.org/W2143655634","https://openalex.org/W2146337514","https://openalex.org/W2146414563","https://openalex.org/W2158761186","https://openalex.org/W2169110374","https://openalex.org/W2185659136","https://openalex.org/W2417836974","https://openalex.org/W2476542314","https://openalex.org/W2530700316","https://openalex.org/W2555999948","https://openalex.org/W2559492425","https://openalex.org/W2568015680","https://openalex.org/W2572293469","https://openalex.org/W2586498847","https://openalex.org/W2593029588","https://openalex.org/W2597096175","https://openalex.org/W2730718150","https://openalex.org/W2750853956","https://openalex.org/W2761761067","https://openalex.org/W2761792472","https://openalex.org/W2791817621","https://openalex.org/W2974201043","https://openalex.org/W2981317732","https://openalex.org/W2991714929"],"related_works":["https://openalex.org/W4380878338","https://openalex.org/W4386071254","https://openalex.org/W2578329095","https://openalex.org/W2915336222","https://openalex.org/W3133906925","https://openalex.org/W4416249118","https://openalex.org/W3095528370","https://openalex.org/W3178222095","https://openalex.org/W2989839786","https://openalex.org/W2781664750"],"abstract_inverted_index":{"The":[0,148],"persistence":[1],"of":[2,18,47,69,86,141,145,183,212,245],"drug":[3],"resistant":[4],"cell":[5,25],"populations":[6],"following":[7],"chemotherapeutic":[8,91,112],"treatment":[9],"is":[10,217],"a":[11,101,107,143,180,191,204],"significant":[12],"challenge":[13],"in":[14,32,65,100,119,193,247],"the":[15,33,58,70,84,111,120,130,169,226,248],"clinical":[16],"management":[17],"cancer.":[19],"Resistant":[20],"subpopulations":[21],"arise":[22],"via":[23],"both":[24],"intrinsic":[26],"and":[27,39,56,67,209,238],"extrinsic":[28],"mechanisms.":[29],"Extrinsic":[30],"factors":[31],"microenvironment,":[34],"including":[35],"neighboring":[36],"cells,":[37],"glycosaminoglycans,":[38],"fibrous":[40,49],"proteins":[41,50],"impact":[42],"therapy":[43],"response.":[44,222],"Elevated":[45],"levels":[46],"extracellular":[48,71],"are":[51],"associated":[52],"with":[53,138,235],"tumor":[54],"progression":[55],"cause":[57],"surrounding":[59],"tissue":[60],"to":[61,76,90,110,129,159,171,188,207,214,219,231],"stiffen":[62],"through":[63],"changes":[64],"structure":[66],"composition":[68],"matrix":[72,194],"(ECM).":[73],"We":[74,198],"sought":[75],"determine":[77],"how":[78],"this":[79,126,176,221],"progressively":[80],"stiffening":[81],"microenvironment":[82],"affects":[83],"sensitivity":[85],"breast":[87,96,115],"cancer":[88],"cells":[89,98,117,154,202],"treatment.":[92],"MDA-MB-231":[93,201],"triple":[94],"negative":[95],"carcinoma":[97,116],"cultured":[99,118],"3D":[102,158],"alginate-based":[103],"hydrogel":[104],"system":[105],"displayed":[106],"stiffness-dependent":[108,127,149,205],"response":[109,135,150,170,237],"doxorubicin.":[113,172],"MCF7":[114],"same":[121],"conditions":[122,166],"did":[123],"not":[124],"exhibit":[125],"resistance":[128,206],"drug.":[131],"This":[132],"differential":[133],"therapeutic":[134,236],"was":[136,151],"coordinated":[137],"nuclear":[139],"translocation":[140],"YAP,":[142],"marker":[144],"mesenchymal":[146],"differentiation.":[147],"lost":[152],"when":[153],"were":[155],"transferred":[156],"from":[157],"monolayer":[160],"cultures,":[161],"suggesting":[162],"that":[163,200,210],"endpoint":[164],"ECM":[165,185,215],"largely":[167],"govern":[168],"To":[173],"further":[174],"examine":[175],"response,":[177],"we":[178],"utilized":[179],"platform":[181],"capable":[182],"dynamic":[184],"stiffness":[186,195,216,234],"modulation":[187],"allow":[189],"for":[190,228,241],"change":[192],"over":[196],"time.":[197],"found":[199],"have":[203],"doxorubicin":[208],"duration":[211],"exposure":[213],"sufficient":[218],"modulate":[220],"These":[223],"results":[224],"indicate":[225],"need":[227],"additional":[229],"tools":[230],"integrate":[232],"mechanical":[233],"inform":[239],"decisions":[240],"more":[242],"effective":[243],"use":[244],"chemotherapeutics":[246],"clinic.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2890625366","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":26},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":29},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-09-27T00:00:00"}
